[1]曾清平.阿托伐他汀联合阿司匹林对高血压伴发动脉粥样硬化患者生活质量的影响[J].医学信息,2025,38(03):130-133.[doi:10.3969/j.issn.1006-1959.2025.03.025]
　ZENG Qingping.Effect of Atorvastatin Combined with Aspirin on Quality of Life in Patients with Hypertension Complicated with Atherosclerosis[J].Journal of Medical Information,2025,38(03):130-133.[doi:10.3969/j.issn.1006-1959.2025.03.025]
点击复制

阿托伐他汀联合阿司匹林对高血压伴发动脉粥样硬化患者生活质量的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
38卷
期数:
2025年03期
页码:
130-133
栏目:
论著
出版日期:
2025-02-01

文章信息/Info

Title:
Effect of Atorvastatin Combined with Aspirin on Quality of Life in Patients with Hypertension Complicated with Atherosclerosis
文章编号:
1006-1959（2025）03-0130-04
作者:
曾清平
遂川县人民医院药剂科，江西 遂川 343900
Author(s):
ZENG Qingping
Department of Pharmacy, Suichuan County People′s Hospital, Suichuan 343900, Jiangxi, China
关键词:
阿托伐他汀; 阿司匹林; 高血压; 动脉粥样硬化; 生活质量
Keywords:
Atorvastatin;  Aspirin;  Hypertension;  Arteriosclerosis;  Quality of life
分类号:
R544.1
DOI:
10.3969/j.issn.1006-1959.2025.03.025
文献标志码:
A
摘要:
目的 观察阿托伐他汀+阿司匹林治疗高血压伴发动脉粥样硬化的效果，评估其对患者生活质量的影响。方法 选取遂川县人民医院2020年1月-2023年10月收治的高血压伴发动脉粥样硬化患者70例为研究对象，按照随机数字表法分为对照组35例和观察组35例。对照组选择阿司匹林治疗，观察组在其基础上予以阿托伐他汀治疗。比较两组临床疗效、生活质量水平、血压水平、血脂指标[低密度脂蛋白胆固醇（LDL-C）、高密度脂蛋白胆固醇（HDL-C）、总胆固醇（TC）、三酰甘油（TG）]、颈动脉内膜中层厚度（CIMT）以及不良反应发生率。结果 观察组治疗总有效率为94.29%，与对照组的85.71%比较，差异有统计学意义（P＜0.05）；与治疗前相比，两组生活质量评分均提高，且与对照组比较，观察组生活质量评分更高（P＜0.05）；与治疗前相比，两组收缩压、舒张压均降低，且与对照组比较，且观察组收缩压、舒张压更低（P＜0.05）；与治疗前相比，两组LDL-C、TC、TG均降低，HDL-C升高，且与对照组比较，观察组LDL-C、TC、TG水平更低，HDL-C更高（P＜0.05）；两组治疗后CIMT均小于治疗前，且与对照组比较，观察CIMT更小（P＜0.05）；观察组不良反应发生率与对照组比较，差异无统计学意义（P＞0.05）。结论 阿托伐他汀+阿司匹林治疗高血压伴发动脉粥样硬化的临床效果确切，可提高患者生活质量水平，改善血脂指标，降低血压水平，减小颈动脉内膜中层厚度，同时不增加不良反应，具有良好的应用有效性和安全性。
Abstract:
Objective To observe the effect of atorvastatin + aspirin in the treatment of hypertension with atherosclerosis, and to evaluate its effect on the quality of life. Methods Using the random number table method, totally 70 patients with hypertension and atherosclerosis admitted to Suichuan County People’s Hospital from January 2020 to October 2023 were divided into control group (n=35) and observation group (n=35). The control group was treated with aspirin, and the observation group was treated with atorvastatin on the basis of the control group. The control group was treated with aspirin, and the observation group was treated with atorvastatin on the basis of the control group. The clinical efficacy, quality of life level, blood pressure level, blood lipid indexes [low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), total cholesterol (TC), triglyceride (TG)], carotid intima-media thickness (CIMT) and incidence of adverse reactions were compared between the two groups. Results The total effective rate of treatment in the observation group was 94.29%, which was compared with 85.71% in the control group, the difference was statistically significant (P<0.05). Compared with before treatment, the quality of life scores of the two groups were improved, and the quality of life score of the observation group was higher than that of the control group (P<0.05). Compared with before treatment, the systolic blood pressure and diastolic blood pressure of the two groups decreased, and compared with the control group, the systolic blood pressure and diastolic blood pressure of the observation group were lower (P<0.05). Compared with before treatment, the levels of LDL-C, TC and TG in the two groups decreased, and HDL-C increased. Compared with the control group, the levels of LDL-C, TC and TG in the observation group were lower, and HDL-C was higher (P<0.05). The CIMT of the two groups after treatment was less than that before treatment, and compared with the control group, the CIMT was smaller (P<0.05). There was no significant difference in the incidence of adverse reactions between the observation group and the control group (P>0.05). Conclusion Atorvastatin combined with aspirin is effective in the treatment of patients with hypertension and atherosclerosis, which can improve their quality of life, improve blood lipid indexes, reduce blood pressure levels, and reduce carotid intima-media thickness without increasing adverse reactions. It has good application effectiveness and safety.

参考文献/References:

[1]吕剑,李佳澄. 彩超评价高血压患者颈动脉粥样硬化与血流动力学变化的价值[J].数理医药学杂志,2021,34(8):1143-1145.[2]Porwal A,Dwivedi H,Pathak K.Gastroretentive bilayer film for sustained release of atorvastatin calcium and immediate release of amlodipine besylate:pharmaceutical,pharmacokinetic evaluation,and IVIVC[J].Pharm Dev Technol,2020,25(4):416-431.[3]Verhaar BJH,Prodan A,Nieuwdorp M,et al.Gut microbiota in hypertension and atherosclerosis: a review[J].Nutrients,2020,12(10):2982.[4]吴立昊,刘成赟,胡鹏云.阿托伐他汀和阿司匹林治疗高血压伴动脉粥样硬化的效果研究[J].黑龙江中医药,2018,47(3):19-20.[5]张业金,魏晓娜.阿托伐他汀与叶酸片对H型高血压患者同型半胱氨酸及颈动脉粥样硬化的影响[J].河北医学,2019,25(2):226-229.[6]中国高血压防治指南修订委员会,中国高血压联盟,中华医学会心血管病学分会,等.中国高血压防治指南(2018 年修订版)[J].中国心血管杂志,2019,24(1):24-56.[7]王琴,徐英.阿托伐他汀在老年高血压患者伴动脉硬化治疗中的应用研究[J].成都医学院学报,2018,13(4):484-486.[8]孙磊,孟锦,赵宏伟,等.不同剂量阿伐他汀联合阿司匹林治疗原发性高血压并动脉粥样硬化的临床研究 [J].现代生物医学进展,2018,18(4):681-684.[9]刘玉萍.阿司匹林联合阿托伐他汀在高血压伴发动脉粥样硬化病患临床治疗中的疗效观察[J].现代诊断与治疗,2017,28(9):1605-1606.[10]张煜.阿托伐他汀联合阿司匹林治疗高血压伴发动脉粥样硬化的临床效果[J].山西医药杂志,2020,49(6):1373-1375.[11]石梦菊.阿托伐他汀对高血压伴发动脉粥样硬化患者血压与血脂水平的影响[J].现代医学与健康研究,2021,5(3):63-65.[12]李喆,张志敏,卫聪颖,等.氨氯地平阿托伐他汀钙片治疗高血压左心室肥厚效果及其与炎性因子关系的研究[J].海军医学杂志,2019,40(6):575-579．[13]周平安,王保成,尚晓萌.氨氯地平阿托伐他汀钙片治疗高血压伴发冠心病效果及对颈动脉粥样硬化和血清Hcy水平的影响[J].哈尔滨医药,2019,25(2):45-47.[14]王启平,朱玉华,钱国权.单核细胞计数/高密度脂蛋白胆固醇比值在评价老年高血压患者颈动脉粥样斑块形成中的意义[J].心脑血管病防治,2020,20(6):579-583.[15]黄兴杰,夏中华,裴芳,等.单核细胞计数/高密度脂蛋白比值变化与原发性高血压患者合并颈动脉粥样硬化的关系[J].广西医学,2020,42(13):1621-1624.[16]姚其彬,张蓓,曾祥弦.益气活血通脉汤治疗高血压伴动脉粥样硬化的疗效及对血脂、炎症介质和氧化应激的影响[J].中西医结合心脑血管病杂志,2021,19(10):3526-3530.[17]陈健,王旺,刘智洋.苯磺酸氨氯地平联合他汀类药物治疗高血压伴颈动脉粥样硬化的效果[J].中国临床医生杂志,2021,12(5):376-380.[18]张振,郭刚.不同剂量黄连素与他汀类药物联合治疗高血压合并动脉粥样硬化的临床疗效[J].心脑血管病防治,2022,20(5):86-90.[19]何秋养,郑石洲.氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的效果观察[J].广东医科大学学报,2019,37(6):671-673.[20]杨丽.阿托伐他汀联合阿司匹林治疗高血压伴动脉粥样硬化的临床疗效评价[J].中国社区医师,2020,36(4):89-92.

相似文献/References:

[1]张文魁.硝酸甘油联合阿司匹林治疗心绞痛的临床效果观察[J].医学信息,2018,31(02):119.[doi:10.3969/j.issn.1006-1959.2018.02.043]
　ZHANG Wen-kui.Clinical Effect of Nitroglycerin Combined with Aspirin in the Treatment of Angina Pectoris[J].Journal of Medical Information,2018,31(03):119.[doi:10.3969/j.issn.1006-1959.2018.02.043]
[2]宇英久,刘 杰.阿司匹林联合硫酸镁治疗妊娠高血压的疗效观察[J].医学信息,2018,31(06):133.[doi:10.3969/j.issn.1006-1959.2018.06.045]
　YU Ying-jiu,LIU Jie.Clinical Observation of Aspirin Combined with Magnesium Sulfate in the Treatment of Pregnancy-induced Hypertension[J].Journal of Medical Information,2018,31(03):133.[doi:10.3969/j.issn.1006-1959.2018.06.045]
[3]何 丽.三种他汀类药物治疗老年动脉粥样硬化性急性脑梗死合并高血脂效果对比[J].医学信息,2022,35(11):150.[doi:10.3969/j.issn.1006-1959.2022.11.040]
　HE Li.Comparison of Three Statins in the Treatment of Elderly Patients with Atherosclerotic Acute Cerebral Infarction Combined with Hyperlipidemia[J].Journal of Medical Information,2022,35(03):150.[doi:10.3969/j.issn.1006-1959.2022.11.040]
[4]王 毅.阿托伐他汀联合曲美他嗪治疗冠心病的临床效果评价[J].医学信息,2018,31(13):139.[doi:10.3969/j.issn.1006-1959.2018.13.041]
　WANG Yi.Clinical Evaluation of Atto Vastatin Combined with Trimetazidine in the Treatment of Coronary Atherosclerotic Heart Disease[J].Journal of Medical Information,2018,31(03):139.[doi:10.3969/j.issn.1006-1959.2018.13.041]
[5]王润俊.阿托伐他汀改善蛛网膜下腔出血患者的预后分析[J].医学信息,2018,31(14):142.[doi:10.3969/j.issn.1006-1959.2018.14.043]
　WANG Run-jun.Analysis of Atorvastatin Improves Prognosis in Patients with Subarachnoid Hemorrhage[J].Journal of Medical Information,2018,31(03):142.[doi:10.3969/j.issn.1006-1959.2018.14.043]
[6]袁 敏,周袁成.阿托伐他汀联合抗血小板药治疗脑血栓患者的疗效及对 血小板参数的影响[J].医学信息,2018,31(16):123.[doi:10.3969/j.issn.1006-1959.2018.16.038]
　YUAN Min,ZHOU Yuan-cheng.Effect of Atorvastatin Combined with Antiplatelet Drugs on Patients with Cerebral Thrombosis and its Influence on Platelet Parameters[J].Journal of Medical Information,2018,31(03):123.[doi:10.3969/j.issn.1006-1959.2018.16.038]
[7]左洪亮.阿司匹林肠溶片治疗缺血性脑血管疾病的临床效果观察[J].医学信息,2018,31(18):118.[doi:10.3969/j.issn.1006-1959.2018.18.037]
　ZUO Hong-liang.Clinical Observation of Aspirin Enteric-coated Tablets in the Treatment of Ischemic Cerebrovascular Disease[J].Journal of Medical Information,2018,31(03):118.[doi:10.3969/j.issn.1006-1959.2018.18.037]
[8]张艳萍,曹 玉,孙国平.服用阿司匹林对乳腺癌患者生存获益的Meta分析[J].医学信息,2018,31(20):72.[doi:10.3969/j.issn.1006-1959.2018.20.021]
　ZHANG Yan-ping,CAO Yu,SUN Guo-ping.Meta Analysis of the Survival Benefit of Patients with Breast Cancer Treated with Aspirin[J].Journal of Medical Information,2018,31(03):72.[doi:10.3969/j.issn.1006-1959.2018.20.021]
[9]徐润鸿.血府逐瘀汤联合阿托伐他汀钙治疗急性脑梗死的临床观察[J].医学信息,2019,32(05):165.[doi:10.3969/j.issn.1006-1959.2019.05.054]
　XU Run-hong.Clinical Observation on Treatment of Acute Cerebral Infarction with Xuefu Zhuyu Decoction Combined with Atorvastatin Calcium[J].Journal of Medical Information,2019,32(03):165.[doi:10.3969/j.issn.1006-1959.2019.05.054]
[10]沈有录,卢红涛,刘维军.阿托伐他汀和瑞舒伐他汀对高海拔地区PCI患者血脂、炎症因子和血管内皮功能的影响[J].医学信息,2019,32(06):67.[doi:10.3969/j.issn.1006-1959.2019.06.022]
　SHEN You-lu,LU Hong-tao,LIU Wei-jun.Effects of Atorvastatin and Rosuvastatin on Blood Lipids,Inflammatory Factors and Vascular Endothelial Function in Patients with High Altitude PCI[J].Journal of Medical Information,2019,32(03):67.[doi:10.3969/j.issn.1006-1959.2019.06.022]

更新日期/Last Update: 1900-01-01